Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia

AmericanPharmaceuticalReviewDecember 03, 2021

Tag: Tryp Therapeutics , Fibromyalgia , psilocybin

PharmaSources Customer Service